(RTTNews) - Abbott (ABT) announced the successful completion of the world's first in-human leadless left bundle branch area pacing procedures using the company's investigational AVEIR Conduction ...
Multicenter randomized trial (n=200) assigned LBBP versus BiVP for CRT in LBBB with LVEF ≤35%, using time to death or HF hospitalization as primary endpoint. Event rates favored LBBP, reducing death ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved an expanded indication for Boston Scientific’s pacemaker leads. The expanded indication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results